Contact

Early is Good Founder Dr. Thakshila Liyanage Unveils Cancer Test at ACS Fall 2021

Early is Good Founder Dr. Liyanage Unveils Cancer Test at ACS Fall 2021

Early is Good founder Dr. Thakshila Liyanage will present a novel biomarker-based bladder cancer test at ACS Fall 2021 in Atlanta, on August 22. The test focuses on enhancing compliance and patient outcomes.

Liyanage T, ACS Fall 2021 Biomarker-based bladder cancer test to improve follow-up testing compliance, clinical outcomes and save more biological bladders Early Carrier Investigation PAPER ID: 3595642

Latest From News

Press Release: Early is Good Receives NIH Phase 2 Grant to Develop Innovative Bladder Cancer Monitoring Test

Press Release: Early is Good Announces Collaboration with Mayo Clinic to Develop a Comprehensive Liquid Biopsy Test for Men with Advanced Prostate Cancer

Early is Good’s founder, Dr. Thakshila Liyanage, will introduce BCDx, a breakthrough in bladder cancer diagnosis test, at the ACS on August 16